ConductScience.org, home

Paper36960966

Therapeutic Effects of WT1 Silencing via Respiratory Administration of Neutral DOPC Liposomal-siRNA in a Lung Metastasis Melanoma Murine Model.

Ramos-Gonzalez MR and 4 others. Noncoding RNA, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic Effects of WT1 Silencing via Respiratory Administration of Neutral DOPC Liposomal-siRNA in a Lung Metastasis Melanoma Murine Model. Papers, record 36960966. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36960966

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic Effects of WT1 Silencing via Respiratory Administration of Neutral DOPC Liposomal-siRNA in a Lung Metastasis Melanoma Murine Model.
PubMed
Journal
Noncoding RNA
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.37
iCite
Revised in PubMed
2023-03-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ramos-Gonzalez MRMartin Rhttps://orcid.org/0000-0002-4794-0417
2Vazquez-Garza EEduardohttps://orcid.org/0000-0001-7149-8334
3Garcia-Rivas GGerardo
4Rodriguez-Aguayo CCristianhttps://orcid.org/0000-0002-7880-7723
5Chavez-Reyes AArturo

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
371665Consejo Nacional de Ciencia y TecnologíaPubMed

Source PubMed

Download CSV of grants

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124384374Liposomal siRNA nanocarriers for cancer therapy.Adv Drug Deliv Rev2014https://conductscience.org/library/papers/24384374PubMed
221744502Current progress of siRNA/shRNA therapeutics in clinical trials.Biotechnol J2011https://conductscience.org/library/papers/21744502PubMed
323237552On the origin of cancer metastasis.Crit Rev Oncog2013https://conductscience.org/library/papers/23237552PubMed
420220130A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.J Biol Chem2010https://conductscience.org/library/papers/20220130PubMed
512654731siRNAs: a new wave of RNA-based therapeutics.J Antimicrob Chemother2003https://conductscience.org/library/papers/12654731PubMed
622734758Monitoring the process of pulmonary melanoma metastasis using large area and label-free nonlinear optical microscopy.J Biomed Opt2012https://conductscience.org/library/papers/22734758PubMed
712750711An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation.Leukemia2003https://conductscience.org/library/papers/12750711PubMed
821256590Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia.Leuk Res2011https://conductscience.org/library/papers/21256590PubMed
919461674WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth.Cancer Gene Ther2009https://conductscience.org/library/papers/19461674PubMed
1022276610High Wilms' tumour gene (WT1) expression and low mitotic count are independent predictors of survival in diffuse peritoneal mesothelioma.Histopathology2012https://conductscience.org/library/papers/22276610PubMed
1117912546The Wilms' tumor suppressor WT1 is associated with melanoma proliferation.Pflugers Arch2008https://conductscience.org/library/papers/17912546PubMed
1217109636Different isoforms of the Wilms' tumour protein WT1 have distinct patterns of distribution and trafficking within the nucleus.Cell Prolif2006https://conductscience.org/library/papers/17109636PubMed
1329116019CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.J Exp Clin Cancer Res2017https://conductscience.org/library/papers/29116019PubMed
1422903384Primary tumor regulates the pulmonary microenvironment in melanoma carcinoma model and facilitates lung metastasis.J Cancer Res Clin Oncol2013https://conductscience.org/library/papers/22903384PubMed
1522933380Psycho-educational interventions for melanoma survivors: a systematic review.Psychooncology2013https://conductscience.org/library/papers/22933380PubMed
1627779659microRNA-361 targets Wilms' tumor 1 to inhibit the growth, migration and invasion of non-small-cell lung cancer cells.Mol Med Rep2016https://conductscience.org/library/papers/27779659PubMed
1719392599Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells.J Neurosurg2010https://conductscience.org/library/papers/19392599PubMed
187808002The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells.Leukemia1994https://conductscience.org/library/papers/7808002PubMed
1920885852WT1 and kidney progenitor cells.Organogenesis2010https://conductscience.org/library/papers/20885852PubMed
2022887049Galangin inhibits tumor growth and metastasis of B16F10 melanoma.J Cell Biochem2013https://conductscience.org/library/papers/22887049PubMed

See all 33 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41171469WT1 gene: a potential therapeutic target for multiple cancer treatment strategies.Clin Exp Med2025https://conductscience.org/library/papers/41171469PubMed
40724842Gene Therapies in Dermatological Diseases: A Breakthrough in Treatment.Int J Mol Sci2025https://conductscience.org/library/papers/40724842PubMed
40125426A Novel Systemic siDR6 Delivery System Based on DP7-C for the Treatment of Metastatic Lung Cancer.Int J Nanomedicine2025https://conductscience.org/library/papers/40125426PubMed
38106451A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy.Int J Nanomedicine2023https://conductscience.org/library/papers/38106451PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36960966

GET https://conductscience.org/api/papers/v1/36960966/references?page=2